CORONA Remedies Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015
CORONA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
CORONA Remedies Limited has informed the stock exchanges that the trading window for dealing in its securities will remain closed from April 01, 2026, until 48 hours after the declaration of its audited financial results for the fourth quarter and financial year ending March 31, 2026. This closure is in line with SEBI's Insider Trading Regulations, 2015 and the company's internal code of conduct. The company has stated that the date of the board meeting to consider and approve these results will be communicated separately. Chetna Dharajiya, Company Secretary and Compliance Officer, signed the filing dated March 30, 2026.
This is a routine regulatory compliance filing and does not have a direct impact on the stock price. It signals that audited Q4 and full-year FY26 results are expected soon, which investors should watch for as it may influence trading sentiment once the trading window reopens.